News + Filings Holdings
All
13F
13D/G
Other
|
|
Bratton Capital Management, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/23/2020 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Disposed of 383,411 shares
@ $0 |
|
| 12/15/2020 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 46,799 shares
@ $80.0539, valued at
$3.7M
Sold 16,949 shares
@ $80.3454, valued at
$1.4M
Sold 876 shares
@ $81.1281, valued at
$71.1k
|
|
| 11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/09/2019 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Disposed of 158,764 shares
@ $0 |
|
| 02/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/26/2018 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 165,000 shares
@ $15, valued at
$2.5M
|
|
| 12/14/2017 |
4
| BRATTON DOUGLAS K (10% Owner) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Converted 14,499,999 shares
@ $0
Converted 2,500,000 shares
@ $0
Converted 1,875,000 shares
@ $0
Converted 743,599 shares
@ $0
Converted 128,200 shares
@ $0
Converted 240,000 shares
@ $0
Bought 275,000 shares
@ $18, valued at
$5M
Converted 14,499,999 convertible preferred
@ $0
Converted 2,500,000 convertible preferred
@ $0
Converted 1,875,000 convertible preferred
@ $0
Converted 743,599 convertible preferred
@ $0 |
|
| 12/07/2017 |
3
| BRATTON DOUGLAS K (10% Owner) has filed a Form 3 on Denali Therapeutics Inc. |
|
|